Shares of Edwards Lifesciences Corp EW are up sharply in Friday's session following the company’s sixth consecutive earnings beat.
For the third quarter 2014; the company reported EPS of $0.80 per share, beating estimates by $0.08 per share or 11 percent. This represents the fourth consecutive instance in which the company beat EPS estimates by at least 10 percent.
Following the beat, shares were experiencing elevated volume; roughly 100 percent greater compared to the past 50 trading days. Moreover, the company raised full year 2014 guidance; expecting to exceed the high end of the previously mentioned range of $2.05 billion to $2.25 billion.
Shares of Edwards Lifesciences recently traded at $117, up 11.8 percent.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.